Suppr超能文献

原发性和继发性肝脏恶性肿瘤不同消融技术局部肿瘤控制的长期比较研究

Long-Term Comparative Study on the Local Tumour Control of Different Ablation Technologies in Primary and Secondary Liver Malignancies.

作者信息

Kovács Attila, Bischoff Peter, Haddad Hathal, Zhou Willi, Temming Susanne, Schäfer Andreas, Spallek Hannah, Kaupe Lucas, Kovács György, Pinkawa Michael

机构信息

Clinic for Diagnostic and Interventional Radiology and Neuroradiology, Mediclin Robert Janker Klinik, 53129 Bonn, Germany.

Clinic for Radiotherapy and Radiooncology, Mediclin Robert Janker Klinik, 53129 Bonn, Germany.

出版信息

J Pers Med. 2022 Mar 9;12(3):430. doi: 10.3390/jpm12030430.

Abstract

Purpose: To evaluate local tumour control (LTC) by local ablation techniques (LAT) in liver malignancies. Materials and methods: In patients treated with LAT between January 2013 and October 2020 target lesions were characterised by histology, dimensions in three spatial axes, volume, vascularisation and challenging (CL) location. LAT used were: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation (CRYO), Electrochemotherapy (ECT), and Interstitial Brachytherapy (IBT). Results: 211 LAT were performed in 155 patients. Mean follow-up including MRI for all patients was 11 months. Lesions treated with ECT and IBT were significantly larger and significantly more often located in CL in comparison to RFA, MWA and CRYO. Best LTC (all data for 12 months are given below) resulted after RFA (93%), followed by ECT (81%), CRYO (70%), IBT (68%) and MWA (61%), and further, entity-related for HCC (93%), followed by CRC (83%) and BrC (72%), without statistically significant differences. LTC in hypovascular lesions was worse (64%), followed by intermediate (82% p = 0.01) and hypervascular lesions (92% p = 0.07). Neither diameter (<3 cm: 81%/3−6 cm: 74%/>6 cm: 70%), nor volume (<10 cm3: 80%/10−20 cm3: 86%/>20 cm3: 67%), nor CL (75% in CL vs. 80% in non CL) had a significant impact on LTC. In CL, best LTC resulted after ECT (76%) and IBT (76%). Conclusion: With suitable LAT, similarly good local tumour control can be achieved regardless of lesion size and location of the target.

摘要

目的

评估局部消融技术(LAT)对肝脏恶性肿瘤的局部肿瘤控制(LTC)情况。材料与方法:对2013年1月至2020年10月期间接受LAT治疗的患者,通过组织学、三维尺寸、体积、血管化程度和具有挑战性(CL)的位置对目标病灶进行特征描述。使用的LAT包括:射频消融(RFA)、微波消融(MWA)、冷冻消融(CRYO)、电化学疗法(ECT)和组织间近距离放射疗法(IBT)。结果:155例患者共进行了211次LAT。所有患者的平均随访时间(包括MRI)为11个月。与RFA、MWA和CRYO相比,ECT和IBT治疗的病灶明显更大,且更常位于CL部位。最佳LTC(以下给出所有12个月的数据)在RFA后出现(93%),其次是ECT(81%)、CRYO(70%)、IBT(68%)和MWA(61%),此外,按实体相关情况,肝癌(HCC)为(93%),其次是结直肠癌(CRC)(83%)和乳腺癌(BrC)(72%),无统计学显著差异。乏血供病灶的LTC较差(64%),其次是中等血供病灶(82%,p = 0.01)和富血供病灶(92%,p = 0.07)。病灶直径(<3 cm:81%/3 - 6 cm:74%/>6 cm:70%)、体积(<10 cm3:80%/10 - 20 cm3:86%/>20 cm3:67%)或CL(CL部位为75%,非CL部位为80%)对LTC均无显著影响。在CL部位,ECT(76%)和IBT(76%)后的LTC最佳。结论:采用合适的LAT,无论病灶大小和目标位置如何,均可实现相似的良好局部肿瘤控制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7a4/8951445/5537f65e98d4/jpm-12-00430-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验